Gimme Care vs. Oak Longevity: prices, fine print, and the honest verdict

Tirzepatide pricing

Gimme Care offers tirzepatide without a published price we could capture. Oak Longevity does not offer tirzepatide.

Semaglutide pricing

Only Oak Longevity publishes a semaglutide price here: Semaglutide runs $133 a month all-in. Gimme Care offers semaglutide without a published price.

Transparency

Gimme Care: No price published (verified 2026-08-05); dispensing pharmacy not publicly named. Oak Longevity: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Gimme Care: unknown; not published. Oak Longevity: none stated; no subscription.

The semaglutide board

Only Oak Longevity fields a verified semaglutide price here — $133/month all-in (#1 of 19) — while Gimme Care publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Gimme Care publishes no figure to normalize; Oak Longevity publishes no figure to normalize. 4 · Evidence tiered. Gimme Care: no price published, read 2026-08-05; Oak Longevity: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Gimme Care names no pharmacy; Oak Longevity names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Gimme Care: no membership — the medication figure is the billed figure; not published; commitment: unknown. Oak Longevity: no membership — the medication figure is the billed figure; no subscription; commitment: none stated. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Gimme Care carries no price published pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Oak Longevity carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Gimme Care-to-Oak Longevity move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Gimme Care: shipping unknown; consultation unknown. Oak Longevity: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Gimme Care if its published terms happen to fit your state, format, or timing. Pick Oak Longevity if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Gimme Care, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.